Overall Score

Growth

Revenue base remains modestly valued at 0.64x sales, but profitability is still weak with TTM net margin at -4.5% and EBIT margin at -0.7%.

Operating cash flow is positive at 2.63 per share, yet free cash flow per share is only 1.14 and FCF yield is 4.0%, limiting self-funded growth.

Profitability

Returns remain negative, with ROA at -2.6%, ROE at -6.3%, and ROIC at 0.8%, indicating limited value creation.

Interest coverage is still very thin at 0.49x and net debt to EBITDA is elevated at 16.0x, constraining financial flexibility.

Financial Health

Liquidity is acceptable with a current ratio of 1.84x and quick ratio of 1.12x, supporting near-term obligations.

Balance sheet leverage remains high, with debt to capital at 46.7% and debt to market cap near 96.9%, offsetting the liquidity cushion.

Valuation

Valuation remains inexpensive on sales and book value, with P/S at 0.64x and P/B at 0.91x.

However, the low multiple is tempered by weak earnings quality and negative earnings, with P/E still not meaningful on a trailing basis.